FacultyFaculty/Author Profile
Eldora L. Ellison, Ph.D.

Eldora L. Ellison, Ph.D.

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Washington, DC, USA


Eldora L. Ellison, Ph.D., is a director in Sterne Kessler’s Biotechnology & Chemical and Trial & Appellate Practice Groups. Over the course of her 24-year career, Eldora has gained extensive experience in inter partes patent matters, building on a strong foundation in patent prosecution. Her experience includes representing clients in over 60 inter partes review and post-grant review proceedings, more than 15 patent interferences, and in various patent reexaminations and district court litigations. For example, Eldora was lead counsel on behalf of patent owner ImmunoGen in Phigenix v. ImmunoGen, 845 F.3d 1168 (Fed. Cir. 2017), in which the Federal Circuit — for the first time since the Court’s inception — established the legal standard for demonstrating standing in an appeal from a final agency action.  The Court subsequently dismissed Phigenix’s IPR appeal for lack of standing. Eldora’s practice also includes preparing and prosecuting patent applications; evaluating patent portfolios (e.g., for due diligence analyses, invalidity, non-infringement, or freedom-to-operate); counseling clients on intellectual property strategy, including Hatch-Waxman issues; and resolving inventorship disputes. She represents a variety of types of clients, including large multinational corporations, start-up companies, and not-for-profit organizations.

Eldora has been recognized as a leading practitioner in the life sciences, and she has served as an expert witness on patent matters. In 2017, LMG Life Sciences named Eldora their "Post Grant Proceedings Attorney of the Year." The National Law Journal recognized her as one of its "Top 50 Litigation Trailblazers. Managing Intellectual Property nominated her for its "PTAB Litigator of the Year" award, and it has named her an "IP Star" in 2017 for the fifth year in a row, while also including her in their "Top 250 Women in IP." LMG Life Sciences nominated her for its "Patent Prosecutor of the Year" award as well as "PTAB Litigator of the Year" in 2016, and it has named her a "Life Sciences Star" three times. In 2016, Profiles in Diversity Journal listed her among "Women Worth Watching." In 2016, IAM Patent 1000 named her as one of the world's leading patent professionals and "highly recommended" for post-grant and procedures and litigation.
Eldora L. Ellison, Ph.D. is associated with the following items:
CHB Chapters  CHB Chapters Roadblock PTAB: Hardening Patent Portfolios and Adjusting Patent Prosecution Strategies - USPTO Post-Grant Patent Trials 2018, Tuesday, May 15, 2018
Web Segment  Web Segment Roadblock PTAB: Hardening Patent Portfolios and Adjusting Patent Prosecution Strategies - USPTO Post-Grant Patent Trials 2018, Monday, September 24, 2018
MP3 Audio  MP3 Audio Roadblock PTAB: Hardening Patent Portfolios and Adjusting Patent Prosecution Strategies - Roadblock PTAB: Hardening Patent Portfolios and Adjusting Patent Prosecution Strategies, Monday, September 24, 2018
Transcripts  Transcripts Roadblock PTAB: Hardening Patent Portfolios and Adjusting Patent Prosecution Strategies - Roadblock PTAB: Hardening Patent Portfolios and Adjusting Patent Prosecution Strategies, Monday, September 24, 2018
MP4 - Mobile Video Seg  MP4 - Mobile Video Seg Roadblock PTAB: Hardening Patent Portfolios and Adjusting Patent Prosecution Strategies - Roadblock PTAB: Hardening Patent Portfolios and Adjusting Patent Prosecution Strategies, Monday, September 24, 2018
On-Demand Web Programs  On-Demand Web Programs USPTO Post-Grant Patent Trials 2018, Friday, September 28, 2018, New York, NY
Share
Email

  • FOLLOW PLI:
  • twitter
  • LinkedIn
  • YouTube
  • RSS

All Contents Copyright © 1996-2018 Practising Law Institute. Continuing Legal Education since 1933.

© 2018 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.